BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Federal Trade Commission
Cantor Fitzgerald
Cipla
Queensland Health
McKesson
Chinese Patent Office
Healthtrust
Daiichi Sankyo
US Department of Justice

Generated: January 21, 2018

DrugPatentWatch Database Preview

Fosinopril sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for fosinopril sodium and what is the scope of fosinopril sodium patent protection?

Fosinopril sodium
is the generic ingredient in four branded drugs marketed by Actavis Labs Fl Inc, Apotex Inc, Aurobindo Pharma Ltd, Invagen Pharms, Prinston Inc, Ranbaxy Labs Ltd, Teva, Upsher-smith Labs, Watson Labs, Bristol Myers Squibb, Aurobindo Pharma, Emcure Pharms India, Mylan, Sandoz, and Sun Pharm Inds Ltd, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for fosinopril sodium. Sixteen suppliers are listed for this compound.
Pharmacology for fosinopril sodium
Medical Subject Heading (MeSH) Categories for fosinopril sodium

US Patents and Regulatory Information for fosinopril sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva FOSINOPRIL SODIUM fosinopril sodium TABLET;ORAL 076139-001 Nov 25, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs FOSINOPRIL SODIUM fosinopril sodium TABLET;ORAL 076987-001 Dec 23, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Invagen Pharms FOSINOPRIL SODIUM fosinopril sodium TABLET;ORAL 077222-003 Apr 20, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher-smith Labs FOSINOPRIL SODIUM fosinopril sodium TABLET;ORAL 076188-001 Oct 8, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 077144-002 Aug 16, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb MONOPRIL-HCT fosinopril sodium; hydrochlorothiazide TABLET;ORAL 020286-001 Nov 30, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd FOSINOPRIL SODIUM fosinopril sodium TABLET;ORAL 091163-003 Mar 30, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs FOSINOPRIL SODIUM fosinopril sodium TABLET;ORAL 077531-001 Aug 31, 2006 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Fl Inc FOSINOPRIL SODIUM fosinopril sodium TABLET;ORAL 076620-001 Oct 15, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ranbaxy Labs Ltd FOSINOPRIL SODIUM fosinopril sodium TABLET;ORAL 076580-002 Apr 23, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for fosinopril sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-003 May 16, 1991 ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-002 May 16, 1991 ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-004 Mar 28, 1995 ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-002 May 16, 1991 ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-003 May 16, 1991 ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-003 May 16, 1991 ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-002 May 16, 1991 ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-004 Mar 28, 1995 ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb MONOPRIL fosinopril sodium TABLET;ORAL 019915-004 Mar 28, 1995 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
QuintilesIMS
Fuji
McKesson
AstraZeneca
Johnson and Johnson
Novartis
Teva
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot